BIO-TECHNE Corp 8-K

What Happened
Bio‑Techne Corporation (TECH) filed an 8‑K on June 25, 2026 disclosing that it and Merck KGaA, Darmstadt, Germany executed an Agreement and Plan of Merger. The merger agreement names EMD Holdings NewCo, Inc. (a Minnesota corporation and wholly‑owned subsidiary of Merck KGaA) as the acquiring entity. The company furnished a joint press release about the transaction (attached as Exhibit 99.1).

Key Details

• Filing date: June 25, 2026; joint press release attached as Exhibit 99.1 (furnished, not filed).
• Parties to the agreement: Bio‑Techne, Merck KGaA, and EMD Holdings NewCo, Inc.
• Item 5.02 references a prior Bio‑Techne 8‑K (filed Feb 11, 2026) concerning departures/elections of directors or officers and compensatory arrangements; any changes in insiders’ security holdings will be reported on Forms 3 or 4.
• The filing states that details about proxy solicitation participants and their interests will be included in the forthcoming proxy statement and related SEC materials.

Why It Matters
A signed merger agreement is a material corporate event that may affect Bio‑Techne’s strategic direction, governance and shareholder value. Investors should watch for the formal proxy statement and other SEC filings for deal terms, potential governance changes, timing, and any required shareholder votes. Also monitor forthcoming Forms 3/4 for insider ownership updates and the company’s additional disclosures about the transaction.